search
Back to results

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

Primary Purpose

Liver and Intrahepatic Bile Duct Neoplasm, Metastatic Malignant Neoplasm in the Liver, Primary Malignant Liver Neoplasm

Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Quality-of-Life Assessment
Surgical Procedure
Surgical Procedure
Sponsored by
M.D. Anderson Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Liver and Intrahepatic Bile Duct Neoplasm

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients undergoing hepatectomy for malignant diagnosis (primary or secondary) from 5/1/2021 through 11/1/2024 will be eligible for inclusion in this study
  • Elective surgery
  • Age >= 18
  • Planned midline laparotomy incision or inverted-L incision

Exclusion Criteria:

  • Pre-existing abdominal hernia
  • History of mesh placement at prior laparotomy
  • Pregnant women

Sites / Locations

  • M D Anderson Cancer CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Arm I (hepatectomy using small bites fascial closure)

Arm II (hepatectomy using conventional fascial method)

Arm Description

Patients undergo hepatectomy as planned using small bites fascial method for abdominal wall closure.

Patients undergo hepatectomy as planned using conventional fascial method for abdominal wall closure.

Outcomes

Primary Outcome Measures

Radiographic incidence rate of incisional hernia
Definition of incisional hernia will be based on the European Hernia Society: Any abdominal wall gap with or without a bulge in the area of a postoperative scar perceptible or palpable by clinical examination or imaging. Assessment of the primary outcome will occur at 3, 6, and 12 months with a computed tomography scan/magnetic resonance imaging. Scans will be read and assessed for incisional hernia by 3 independent assessors blinded to the allocation. A correlation coefficient will be determined for their assessments. The cumulative incidence rate of incisional hernia at 12 months will be estimated, along with the 95% confidence interval.

Secondary Outcome Measures

Surgical site infection
Surgical site occurrence
Surgical site occurrence requiring procedural intervention
Postoperative complications
Post-operative infection, complication or pain will be assessed using Chi-squared test or Fisher's exact test.
Need for reoperation
Need for reoperation secondary to complication of abdominal closure
Length of hospital stay (postoperatively)
Will be compared between the two arms using two-sample t-test or Wilcoxon rank sum test.
Any readmission related to hernia repair
Health-related quality of life assessment
Will use linear mixed effect modeling to assess the effects of time, arm as well as the interaction between arm and time.
Incidence of adverse events (AEs)
Will be summarized using descriptive statistics (frequency, percentage) by arm, AE type, severity and attribution.

Full Information

First Posted
June 18, 2021
Last Updated
June 1, 2023
Sponsor
M.D. Anderson Cancer Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04982653
Brief Title
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
Official Title
Incisional Hernia Prevention After Open Hepatectomy by Small Tissue Bite Fascial Closure: A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
January 4, 2022 (Actual)
Primary Completion Date
April 30, 2026 (Anticipated)
Study Completion Date
April 30, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
M.D. Anderson Cancer Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This clinical trial compares two different kinds of surgical closing techniques, short stitch suture or traditional suture, in patients who are having liver tumor surgery. This study may help researchers learn if one technique can lower the chances of developing a hole in the wall of the abdomen (an abdominal hernia) at the incision site better than the other.
Detailed Description
PRIMARY OBJECTIVE: I. To assess whether small bites abdominal wall closure reduces the risk of developing incisional hernia following liver surgery. SECONDARY OBJECTIVES: I. To compare short-term perioperative outcomes between small bites and typical fascial closure technique. II. To assess the hernia incidence rate of short stich versus (vs.) standard closure in subgroups of patients with inverted-L or midline incisions. III. To assess the hernia incidence rate of Kawaguchi-Gayet hepatectomy complexity classifications I/II vs. III (hernia rate by extent of hepatectomy). IV. To assess the hernia incidence rate of preoperative chemotherapy or no preoperative chemotherapy (hernia rate by exposure to preoperative chemotherapy). V. To assess impact of small bites abdominal wall closure on health care quality of life following liver surgery. VI. To assess safety of small tissue bites fascial closure suture technique versus conventional fascial closure following hepatectomy. OUTLINE: Patients are randomized to 1 of 2 arms. ARM I (INTERVENTION): Patients undergo hepatectomy as planned using small bites fascial method for abdominal wall closure. ARM II (CONTROL): Patients undergo hepatectomy as planned using conventional fascial method for abdominal wall closure. After completion of study, patients are followed up at 1-4 weeks, and then at 3, 6, and 12 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Liver and Intrahepatic Bile Duct Neoplasm, Metastatic Malignant Neoplasm in the Liver, Primary Malignant Liver Neoplasm

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
140 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Arm I (hepatectomy using small bites fascial closure)
Arm Type
Experimental
Arm Description
Patients undergo hepatectomy as planned using small bites fascial method for abdominal wall closure.
Arm Title
Arm II (hepatectomy using conventional fascial method)
Arm Type
Active Comparator
Arm Description
Patients undergo hepatectomy as planned using conventional fascial method for abdominal wall closure.
Intervention Type
Other
Intervention Name(s)
Quality-of-Life Assessment
Other Intervention Name(s)
Quality of Life Assessment
Intervention Description
Ancillary studies
Intervention Type
Procedure
Intervention Name(s)
Surgical Procedure
Other Intervention Name(s)
Operation, Surgery, Surgical, Surgical Intervention, Surgical Interventions, Surgical Procedures, Type of Surgery
Intervention Description
Undergo hepatectomy using small bites fascial method for abdominal wall closure
Intervention Type
Procedure
Intervention Name(s)
Surgical Procedure
Other Intervention Name(s)
Operation, Surgery, Surgical, Surgical Intervention, Surgical Interventions, Surgical Procedures, Type of Surgery
Intervention Description
Undergo hepatectomy using conventional fascial method for abdominal wall closure
Primary Outcome Measure Information:
Title
Radiographic incidence rate of incisional hernia
Description
Definition of incisional hernia will be based on the European Hernia Society: Any abdominal wall gap with or without a bulge in the area of a postoperative scar perceptible or palpable by clinical examination or imaging. Assessment of the primary outcome will occur at 3, 6, and 12 months with a computed tomography scan/magnetic resonance imaging. Scans will be read and assessed for incisional hernia by 3 independent assessors blinded to the allocation. A correlation coefficient will be determined for their assessments. The cumulative incidence rate of incisional hernia at 12 months will be estimated, along with the 95% confidence interval.
Time Frame
Up to 12 months after surgery
Secondary Outcome Measure Information:
Title
Surgical site infection
Time Frame
Up to 90 days after surgery
Title
Surgical site occurrence
Time Frame
Up to 90 days after surgery
Title
Surgical site occurrence requiring procedural intervention
Time Frame
Up to 90 days after surgery
Title
Postoperative complications
Description
Post-operative infection, complication or pain will be assessed using Chi-squared test or Fisher's exact test.
Time Frame
Up to 90 days after surgery
Title
Need for reoperation
Time Frame
Up to 90 days after surgery
Title
Need for reoperation secondary to complication of abdominal closure
Time Frame
Up to 90 days after surgery
Title
Length of hospital stay (postoperatively)
Description
Will be compared between the two arms using two-sample t-test or Wilcoxon rank sum test.
Time Frame
Up to 90 days after surgery
Title
Any readmission related to hernia repair
Time Frame
Up to 30 days after surgery
Title
Health-related quality of life assessment
Description
Will use linear mixed effect modeling to assess the effects of time, arm as well as the interaction between arm and time.
Time Frame
Up to 12 months after surgery
Title
Incidence of adverse events (AEs)
Description
Will be summarized using descriptive statistics (frequency, percentage) by arm, AE type, severity and attribution.
Time Frame
Up to 90 days after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients undergoing hepatectomy for malignant diagnosis (primary or secondary) from 5/1/2021 through 11/1/2024 will be eligible for inclusion in this study Elective surgery Age >= 18 Planned midline laparotomy incision or inverted-L incision Exclusion Criteria: Pre-existing abdominal hernia History of mesh placement at prior laparotomy Pregnant women
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Timothy E Newhook, MD
Phone
713-792-6940
Email
TNewhook@mdanderson.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Timothy E Newhook, MD
Organizational Affiliation
M.D. Anderson Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
M D Anderson Cancer Center
City
Houston
State/Province
Texas
ZIP/Postal Code
77030
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Timothy E. Newhook
Phone
713-792-6940
Email
TNewhook@mdanderson.org
First Name & Middle Initial & Last Name & Degree
Timothy E. Newhook

12. IPD Sharing Statement

Links:
URL
http://www.mdanderson.org
Description
MD Anderson Cancer Center

Learn more about this trial

Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy

We'll reach out to this number within 24 hrs